JMP Securities Issues Positive Forecast for Taysha Gene Therapies (NASDAQ:TSHA) Stock Price
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective boosted by JMP Securities from $5.00 to $6.00 in a research note published on Thursday,Benzinga reports. They currently have a market outperform rating on the stock. A number of other research analysts have also issued reports on TSHA. Canaccord Genuity Group increased their target […]
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective boosted by JMP Securities from $5.00 to $6.00 in a research note published on Thursday,Benzinga reports. They currently have a market outperform rating on the stock. A number of other research analysts have also issued reports on TSHA. Canaccord Genuity Group increased their target […]
